Article (Scientific journals)
Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis.
Réeff, Jonathan; Oprenyeszk, Frédéric; Franck, Thierry et al.
2015In International Journal of Pharmaceutics, 490, p. 74-84
Peer Reviewed verified by ORBi
 

Files


Full Text
Réeff et al, 2015.pdf
Publisher postprint (1.96 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] This study aimed to evaluate glycerol monooleate (GMO) as a carrier to develop viscoelastic and injectable sustained-release drug delivery systems. The potential pro- and antioxidant activity of the developed hydrolipidic gels were evaluated by measuring the production of ROS by polymorphonuclear leukocytes (PMNs). In addition, the biocompatibility and effectiveness of two selected gel candidates were evaluated in vivo by evaluating the benefit of a single intraarticular injection of these new treatments in a model of osteoarthritis in rabbits. The in vitro study demonstrated that the carrier F1 did not have a pro-oxidative effect and even protected PMNs against natural auto-activation, regardless of the incorporation of either clonidine chlorhydrate or betamethasone dipropionate. The in vivo study demonstrated that F1 and F1-BDP induced a loss of cartilage quality in comparison to the control and reference groups but that the lesions of cartilage observed were generally mild, with not much full-depth erosion. Moreover, no exacerbating inflammation was observed when considering the synovial membranes and the PGE2 and CRP levels. These results seemed to demonstrate that the sustained-release formulation based on GMO could be well-tolerated after intraarticular injection. Moreover, it could have the potential to prevent inflammatory conditions while sustaining drug activity locally over weeks.
Disciplines :
Rheumatology
Author, co-author :
Réeff, Jonathan;  Université Libre de Bruxelles - ULB > Laboratory of Pharmaceutics and Biopharmaceutics
Oprenyeszk, Frédéric ;  Université de Liège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartilage (U.R.O.C.)
Franck, Thierry  ;  Université de Liège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Goole, Jonathan;  Université Libre de Bruxelles - ULB > Laboratory of Pharmaceutics and Biopharmaceutics
De Vriese, Carine;  Université Libre de Bruxelles - ULB > Laboratory of Pharmaceutics and Biopharmaceutics
Serteyn, Didier  ;  Université de Liège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Anesthésiologie gén. et pathologie chirurg. des grds animaux
Henrotin, Yves  ;  Université de Liège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartilage (U.R.O.C.)
Amighi, Karim;  Université Libre de Bruxelles - ULB > Laboratory of Pharmaceutics and Biopharmaceutics
Language :
English
Title :
Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis.
Publication date :
28 April 2015
Journal title :
International Journal of Pharmaceutics
ISSN :
0378-5173
eISSN :
1873-3476
Publisher :
Elsevier, Netherlands
Volume :
490
Pages :
74-84
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 26 May 2015

Statistics


Number of views
64 (4 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
5
Scopus citations®
without self-citations
5
OpenCitations
 
5

Bibliography


Similar publications



Contact ORBi